The Medical Advisor

Can Ivermectin play a key role in treating Parkinson's Disease? Two peer reviewed papers (2020 paper by Warnecke et al, 2024 paper by Wadsworth et al) and a 2021 PhD Thesis by Dongwook Wi strongly suggest it can. This is all new research in the past 3 years.  Here are some highlights. 2020 Warnecke et al :  “The present study found that Ivermectin significantly altered rotational behavior in male and female mice using a mouse model of DA-depletion demonstrating significant differences based on sex." "The findings implicate the potential use of Ivermectin as a lead candidate for use as a novel adjunct therapy in combination with L-DOPA for Parkinson's Disease patients.”  2021 Dongwook Wi PhD Thesis :  “The possible application of Ivermectin (IVM) in conjunction with L-DOPA for PD patients was introduced as a new treatment therapy in this study. By showing the efficacy of IVM on two PD animal models, including MPTP and 6-OHDA...

Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Appendix Cancer Breast Cancer Success Stories (13 cases) Brain Cancer (Glioblastoma) Bile Duct Cancer (Cholangiocarcinoma) Bladder Cancer Success Stories (5 cases) Cervical Cancer Colorectal Cancer (11 cases) Esophageal and Stomach cancer Endometrial Cancer (4 cases) Gastric (Stomach) cancer (3 cases) Head and Neck Cancer (7 cases) Kidney Cancer Case Series (8 cases) Liver Cancer (2 cases) Lung Cancer (11 cases) Leukemia (2 cases) Lymphoma (4 cases) Melanoma (Skin Cancer) Multiple Myeloma Myelodysplastic Syndrome Oral Cancer Ovarian Cancer (2 cases) Pancreatic Cancer (9 cases) Prostate Cancer (15 cases) Sarcoma (2 cases) Skin Cancer (8 cases) ...